📰 Chosa Aps News
Chosa Aps News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Chosa Aps. Real-time updates on events, politics, business and more.
November 16, 2022
15.11.2022 - Press release Cambridge, MA U.S.A. (November 15, 2022) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP companion diagnostics ...
October 18, 2022
EQS-News: Allarity Therapeutics, Inc. Precision Medicine Could Get Even More Precise With Allarity Therapeutics’ “Next-Generation” Diagnostics Platform 18.10.2022 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. Once brought into its pipeline, Allarity uses...
October 12, 2022
Cambridge, MA U.S.A. (October 11, 2022) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing...
September 12, 2022
Press release Cambridge, MA U.S.A. — Allarity Therapeutics, Inc. , a clinical-stage pharmaceutical company developing novel oncology therapeutics together with... | September 12, 2022
June 15, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
May 27, 2022
Cambridge, MA U.S.A. (May 27, 2022) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel...
May 18, 2022
Cambridge, MA U.S.A. (May 18, 2022) — Allarity Therapeutics, Inc. (NASDAQ: ALLR) announced today that its press release issued under the headline “Allarity...
April 23, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
April 23, 2022
Allarity Therapeutics Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250 Cambridge, MA U.S.A. - Allarity Therapeutics, Inc. , a clinical-stage... | April 22, 2022